Rare independent mutations in renal salt handling genes contribute to blood pressure variation
Top Cited Papers
- 6 April 2008
- journal article
- research article
- Published by Springer Nature in Nature Genetics
- Vol. 40 (5) , 592-599
- https://doi.org/10.1038/ng.118
Abstract
The effects of alleles in many genes are believed to contribute to common complex diseases such as hypertension. Whether risk alleles comprise a small number of common variants or many rare independent mutations at trait loci is largely unknown. We screened members of the Framingham Heart Study (FHS) for variation in three genes—SLC12A3 (NCCT), SLC12A1 (NKCC2) and KCNJ1 (ROMK)—causing rare recessive diseases featuring large reductions in blood pressure. Using comparative genomics, genetics and biochemistry, we identified subjects with mutations proven or inferred to be functional. These mutations, all heterozygous and rare, produce clinically significant blood pressure reduction and protect from development of hypertension. Our findings implicate many rare alleles that alter renal salt handling in blood pressure variation in the general population, and identify alleles with health benefit that are nonetheless under purifying selection. These findings have implications for the genetic architecture of hypertension and other common complex traits.Keywords
This publication has 51 references indexed in Scilit:
- A Common Allele on Chromosome 9 Associated with Coronary Heart DiseaseScience, 2007
- Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controlsNature, 2007
- A Genome-Wide Association Study of Type 2 Diabetes in Finns Detects Multiple Susceptibility VariantsScience, 2007
- A Common Variant in the FTO Gene Is Associated with Body Mass Index and Predisposes to Childhood and Adult ObesityScience, 2007
- Transcriptional and Functional Analyses of SLC12A3 MutationsJournal of the American Society of Nephrology, 2007
- Population-based resequencing of ANGPTL4 uncovers variations that reduce triglycerides and increase HDLNature Genetics, 2007
- Major Outcomes in High-Risk Hypertensive Patients Randomized to Angiotensin-Converting Enzyme Inhibitor or Calcium Channel Blocker vs Diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)JAMA, 2002
- Identification of fifteen novel mutations in the SLC12A3 gene encoding the Na-Cl Co-transporter in Italian patients with Gitelman syndromeHuman Mutation, 2002
- The renal tubular Na–Cl co‐transporter (NCCT): a potential genetic link between blood pressure and bone density?Nephrology Dialysis Transplantation, 2001
- Evidence for a Gene Influencing Blood Pressure on Chromosome 17Hypertension, 2000